-- (Updates to add stock movement in the headline and last paragraph)
ResMed (ASX:RMD) reported Friday fiscal third-quarter non-GAAP earnings of $2.86 per share, up from $2.37 a year earlier.
Analysts polled by FactSet expected earnings of $2.80.
Revenue for the three months ended March 31 was $1.43 billion, compared with $1.29 billion a year earlier. Analysts surveyed by FactSet expected $1.42 billion.
The company expects its fiscal 2026 non-GAAP gross margin to be between 62% and 63%.
The board declared a quarterly dividend of $0.60 per share, up from $0.53 a year earlier, payable June 18 to shareholders on record as of May 14.
The company's shares fell past 4% in recent Friday trade, earlier hitting their lowest level since February 2024.